![](/sites/default/files/styles/medium/public/Busting%20with%20Life%20poster%20July%202%202019%20website_1.jpg?itok=R5Y1m7gO)
Have you or someone you know had breast cancer and want to try something new?
Come and give dragon boating a go.
It's fun, great for fitness and proven to be beneficial for breast cancer survivors. Come and find out what dragon boating is all about at one of our monthly regattas over the winter from May onwards.
Become part of a team of women who participate in this sport whilst having a huge amount of fun. We'd love you to join us.
![](/sites/default/files/styles/medium/public/Look%20Good%20Feel%20Better%20Feb%202020%20websize.jpg?itok=M8XPYaYg)
Look Good Feel Better FREE classes are for any person, facing any cancer, at any time in their treatment. Anyone who has been diagnosed and is undergoing treatment for cancer can register.
![](/sites/default/files/styles/medium/public/beautiful-beautiful-girl-brunette-705821.jpg?itok=BmVZpsL_)
A study comparing annual breast screening to screening personalised according to a woman’s risk was presented at the San Antonio Breast Cancer Symposium.
BCAC Secretary Fay Sowerby, who attended the presentation, says she was intrigued by this new trial, WISDOM. Annual screening is standard in the United States, whereas screening takes place every two years for women in NZ.
![Dr Rashmi Murthy. Photo credit: Bruce Jancin/MDedge News](/sites/default/files/styles/medium/public/Dr%20Rashmi%20Murthy%20-%20Photo%20credit%20Bruce%20Jancin%20-%20MDedge%20News.jpg?itok=wyAGr5Py)
A clinical trial shows that tucatinib, an investigative therapy used in combination with trastuzumab and capecitabine, reduces risk of death at two years by one-third in women with HER2-positive metastatic breast cancer (HER2+ MBC).
![Some of the key people instrumental in securing Ibrance funding](/sites/default/files/styles/medium/public/Ibrance%20-%20people%20collage.jpg?itok=pEfKZcCv)
BCAC media release, 15 January 2020: Breast Cancer Aotearoa Coalition (BCAC) is delighted to hear that Ibrance (palbociclib) will be funded by PHARMAC from 1 April 2020.
![Intrepid duo Julian and Camilla Cox](/sites/default/files/styles/medium/public/Bicycle%20ride%20photo.jpg?itok=5dH2xtBn)
BCAC would love you to show support for an intrepid couple who cycled from Dunedin to Parliament to garner support for a petition that would help improve the lives of women with breast cancer and people with other diseases.
![Patient advocates at the San Antonio Breast Cancer Symposium 2019](/sites/default/files/styles/medium/public/Advocates%20at%20SABCS.jpg?itok=kU1KbliX)
Advocates are always a big part of the San Antonio Breast Cancer Symposium, with wonderful opportunities to share ideas, experience, priorities and plans. This photo shows patient advocates together in Texas. The photo is courtesy of the Alamo Breast Cancer Foundation, which we are very pleased sponsored our Deputy Chair Emma Crowley to attend the Symposium.
![](/sites/default/files/styles/medium/public/rawpixel-618738-unsplash.jpg?itok=ubEMeDCl)
BCAC Secretary Fay Sowerby says a presentation on proteomics was one of the highlights of the San Antonio Breast Cancer Symposium. Tao Liu, from Pacific Western University described advanced enabling technologies for cancer proteomics developed to be efficient and replicable to handle bulk proteomics workflow typically handling 10,000 proteins and greater than
![Photo credit: San Antonio Breast Cancer Symposium](/sites/default/files/styles/medium/public/SABCS%20banners.jpg?itok=L-vHx7Fx)
Initial trial results on the cost and effectiveness of MRI breast cancer screening compared to mammography, in women with a familial risk, have been presented at the San Antonio Breast Cancer Symposium. The FaMRIsc study is the first randomised trial that has made this comparison.
![BCAC Secretary Fay Sowerby. Photo by Shoshana Maasland](/sites/default/files/styles/medium/public/Fay%20Sowerby%20photo%20-%20breast%20density%20article%20-%20Te%20Waha%20Nui.jpg?itok=bfudxp1h)
By Shoshana Maasland, Te Waha Nui (AUT University). Photo also by Shoshana
Fay Sowerby was already involved in breast cancer research when she was diagnosed with the illness. The secretary of Breast Cancer Aotearoa Coalition was well-informed and had been having annual mammograms and occasional ultrasounds. She had recently received an all-clear letter advising she wouldn’t need another mammogram for two years. Four months later, though, she felt a lump.